Industry-academia collaborations are key for the development of new medical technologies and drugs that can provide better care for our patients. The Mass General Research Institute recognizes the importance of these relationships in moving healthcare forward and has increased its efforts to work collaboratively with industry. This has led to an 18% increase in industry-sponsored researchRead more
Blog
Researchers have been looking for a safe, fast, less expensive and more accurate way to identify early signs of treatment resistance, while also searching for new insights into the genetic changes that occur within tumor cells to drive this resistance. This way, new therapy plans can be considered sooner, giving the patient a better chance for their best possible outcome.